Downregulation of CuZn-superoxide dismutase contributes to beta-adrenergic receptor-mediated oxidative stress in the heart.

OBJECTIVE Sustained beta-adrenergic receptor (beta-AR) activation augments oxidative stress in the heart; whether alterations in antioxidant enzymes contribute to this effect is unknown. METHODS AND RESULTS Adult male Wistar rats were implanted with osmotic minipumps to infuse either l-isoproterenol (ISO, 25 microg/kg/h) or saline (SAL). After 7-days, ISO-treated hearts exhibited significant (p<0.005): 1) concentric hypertrophy and augmentation of systolic function, 2) reductions of end-systolic wall stress, and 3) augmentation of oxidative stress, with a approximately 3-fold increase in 4-hydroxy-2-nonenal-and malondialdehyde-protein adducts. ISO-treated hearts also exhibited significant (p<0.01) reductions of CuZn-superoxide dismutase (SOD) enzyme activity (30%), protein (40%), and mRNA (60%), without changes in Mn-SOD, catalase, or glutathione peroxidase. Elk-1 and YinYang1 (YY1) are transcription factors that positively and negatively regulate CuZn-SOD expression, respectively. ISO-treated hearts exhibited a 3-fold increase in YY1 and a 2-fold reduction in Elk-1 DNA binding activity, strongly favoring CuZn-SOD gene repression. In isolated cardiomyocytes, sustained (24 h) ISO stimulation significantly (p<0.01) increased reactive oxygen species (ROS), an effect blocked by CGP20712A, a beta1-AR antagonist, but not by ICI118,551, a beta2-AR antagonist. CuZn-SOD downregulation paralleled the increase in ROS, and were similarly blocked by beta1- but not beta2-AR blockade. There were no changes in CuZn-SOD mRNA stability or myocyte size with ISO treatment. However, nuclear run-on revealed a 40% reduction in CuZn-SOD mRNA expression (p<0.01), consistent with transcriptional repression. ISO also depressed total cellular antioxidant capacity, reduced glutathione (GSH) levels, and the GSH:GSSG ratio. Moreover, CuZn-SOD siRNA transfection of H9c2 cardiomyocytes to suppress CuZn-SOD protein by approximately 40-50% (analogous to the in vivo changes) induced cellular apoptosis. CONCLUSIONS Sustained beta-AR stimulation transcriptionally downregulates CuZn-SOD in myocardium via the beta1-AR, thereby contributing to beta-AR-mediated oxidative stress.

[1]  M. Lohse,et al.  Progressive hypertrophy and heart failure in beta1-adrenergic receptor transgenic mice. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[2]  P. Singal,et al.  Effects of probucol on changes of antioxidant enzymes in adriamycin-induced cardiomyopathy in rats. , 2000, Cardiovascular research.

[3]  E. Stadtman,et al.  Characterization of epitopes recognized by 4-hydroxy-2-nonenal specific antibodies. , 1995, Archives of biochemistry and biophysics.

[4]  C. Long,et al.  Yin Yang 1 Is Increased in Human Heart Failure and Represses the Activity of the Human α-Myosin Heavy Chain Promoter* , 2003, Journal of Biological Chemistry.

[5]  X. Khawaja,et al.  Probing for drug-induced multiplex signal transduction pathways using high resolution two-dimensional gel electrophoresis: application to beta-adrenoceptor stimulation in the rat C6 glioma cell. , 1999, Brain research. Molecular brain research.

[6]  M. Bristow.  β-Adrenergic Receptor Blockade in Chronic Heart Failure , 2000 .

[7]  G. Freeman,et al.  beta-adrenergic blockade in developing heart failure: effects on myocardial inflammatory cytokines, nitric oxide, and remodeling. , 2000, Circulation.

[8]  D. Kang,et al.  Mitochondrial DNA Damage and Dysfunction Associated With Oxidative Stress in Failing Hearts After Myocardial Infarction , 2001, Circulation research.

[9]  M. Pfeffer,et al.  Progressive ventricular remodeling in response to diffuse isoproterenol-induced myocardial necrosis in rats. , 1994, Circulation research.

[10]  M S Chang,et al.  Positive and negative regulatory elements in the upstream region of the rat Cu/Zn-superoxide dismutase gene. , 1999, The Biochemical journal.

[11]  D. Sawyer,et al.  &bgr;-Adrenergic Receptor–Stimulated Apoptosis in Cardiac Myocytes Is Mediated by Reactive Oxygen Species/c-Jun NH2-Terminal Kinase–Dependent Activation of the Mitochondrial Pathway , 2003, Circulation research.

[12]  A. Diwan,et al.  Murine echocardiography: a practical approach for phenotyping genetically manipulated and surgically modeled mice. , 2005, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[13]  G. Dorn,et al.  Early and delayed consequences of beta(2)-adrenergic receptor overexpression in mouse hearts: critical role for expression level. , 2000, Circulation.

[14]  G. Hasenfuss,et al.  Gene expression of antioxidative enzymes in the human heart: increased expression of catalase in the end-stage failing heart. , 2000, Circulation.

[15]  L. Opie,et al.  Adrenaline-induced "oxygen-wastage" and enzyme release from working rat heart. Effects of calcium antagonism, beta-blockade, nicotinic acid and coronary artery ligation. , 1979, Journal of molecular and cellular cardiology.

[16]  B. Parsons,et al.  Adrenergic Effects on the Biology of the Adult Mammalian Cardiocyte , 1992, Circulation.

[17]  S. Prabhu,et al.  Prolonged oxidative stress inverts the cardiac force-frequency relation: role of altered calcium handling and myofilament calcium responsiveness. , 2006, Journal of molecular and cellular cardiology.

[18]  B. Chandrasekar,et al.  Lipid peroxidation-derived aldehydes and oxidative stress in the failing heart: role of aldose reductase. , 2002, American journal of physiology. Heart and circulatory physiology.

[19]  B. Chandrasekar,et al.  Chronic beta-adrenergic stimulation induces myocardial proinflammatory cytokine expression. , 2000, Circulation.

[20]  D. Sawyer,et al.  Role of oxidative stress in myocardial hypertrophy and failure. , 2002, Journal of molecular and cellular cardiology.

[21]  G. Freeman,et al.  Induction of proinflammatory cytokine and antioxidant enzyme gene expression following brief myocardial ischaemia , 1997, Clinical and experimental immunology.

[22]  G. Freeman,et al.  Induction of nuclear factor κB but not κB-responsive cytokine expression during myocardial reperfusion injury after neutropenia , 2000 .

[23]  K. Davies,et al.  Mitochondrial free radical generation, oxidative stress, and aging. , 2000, Free radical biology & medicine.

[24]  B. Chandrasekar,et al.  β-Adrenergic stimulation induces interleukin-18 expression via β2-AR, PI3K, Akt, IKK, and NF-κB , 2004 .

[25]  A. Nishiyama,et al.  Cardiac oxidative stress in acute and chronic isoproterenol-infused rats. , 2005, Cardiovascular research.

[26]  G. Newton,et al.  Vitamin C Augments the Inotropic Response to Dobutamine in Humans With Normal Left Ventricular Function , 2001, Circulation.

[27]  P. Ping,et al.  Beta-adrenergic receptor blockade modulates Bcl-X(S) expression and reduces apoptosis in failing myocardium. , 2003, Journal of molecular and cellular cardiology.

[28]  C. Liang,et al.  Antioxidant vitamins prevent cardiomyocyte apoptosis produced by norepinephrine infusion in ferrets. , 2001, Cardiovascular research.

[29]  D. Sawyer,et al.  Antioxidants and myocardial contractility: illuminating the "Dark Side" of beta-adrenergic receptor activation? , 2001, Circulation.

[30]  G. Freeman,et al.  Altered LV inotropic reserve and mechanoenergetics early in the development of heart failure. , 2000, American journal of physiology. Heart and circulatory physiology.

[31]  Catherine Communal,et al.  Opposing Effects of β1- and β2-Adrenergic Receptors on Cardiac Myocyte Apoptosis Role of a Pertussis Toxin–Sensitive G Protein , 1999 .

[32]  Y. Ho,et al.  Targeted disruption of the mouse Sod I gene makes the hearts vulnerable to ischemic reperfusion injury. , 2000, Circulation research.